Objective: To study the expression levels of the NOK (novel oncogene with kinase-domain) gene in renal cell carcinoma (RCC) and its association with the progression of this cancer. Methods: In this study, immunohistochemistry (IHC) and Western blot analyses were applied to investigate the NOK expression level in RCC and adjacent normal renal tissue samples. MTT, colony formation, and migration assays were also utilized to evaluate the role of NOK in RCC cell lines. Results: Knocked-down expression of NOK in an RCC cell line (786-O) suppressed cellular proliferation and migration by restraining the activation of AKT and ERK. We found that the expression level of NOK was significantly higher in RCC tissues than in their adjacent tissues, and more importantly, overexpression of NOK was evidently correlated with the tumor TNM stage and Fuhrman grade (P<0.001). A high level of NOK was also associated with poor overall survival (P<0.05) and disease-free survival AB068. The splicing factor SRSF1 expression in human bladder carcinoma cells
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Objective: SRSF1 is a splicing factor often times described as an oncoprotein. In the present work, we examined the expression of SRSF1 in human bladder carcinoma cells and detected the change of SRSF1 expression in BIU-87 cells after the treatment of chemotherapeutic drug. Methods: Human bladder carcinoma cells (BIU-87) were treated by growth factors with or without chemotherapeutic drug (pirarubicin) agents' interference. The confirmed of SRSF1 expression in BIU-87 cells and the assessment of the chemotherapeutic drug's function to SRSF1 protein was analyzed by Western blot. Results: SRSF1 precisely expressed in human bladder carcinoma cells-BIU-87 cell line. Protein levels of SRSF1 significantly decreased after pirarubicin treatment in a higher concentration (1.6, 3.2 ug/mL) while slightly
